Tobramycin sulfate is the sulfate salt of tobramycin, an aminoglycoside antibiotic active against gram-negative bacteria including most Enterobacteriaceae, Pseudomonas aeruginosa and a few gram-positive bacteria such as Staphylococcus aureus.
Indication: Used in the treatment of septicemia (bloodstream infection), infections of the skin, bone, lower respiratory tract, central nervous system, intra-abdominal and complicated recurrent urinary tract infections.
Application: Administered systemically by intramuscular injections or intravenous infusions, locally as ophthalmic solution, conjunctival ointment or by inhalation. Can be mixed with bone cement.
Product grades |
Sterile, non-micronized Non-sterile, non-micronized | |||||
Compliance |
USP |
|||||
Manufacturing site |
Xellia Pharmaceuticals ApS, Copenhagen, Denmark |
|||||
Release site |
Xellia Pharmaceuticals ApS, Copenhagen, Denmark |
|||||
Site registered |
EU GMP issued by Danish Medicines Agency US FDA Other health authorities |
|||||
Regulatory documentation |
EU Drug Master File (DMF) US Drug Master File (DMF) DMF also available in other selected countries outside EU/US |
|||||
Packaging sizes |
|
|||||
Packaging material |
|
|||||
Shelf life |
| |||||
Storage conditions |
| |||||
